CN102827085A - Preparation method for 2,4,5-trichloropyrimidine compound - Google Patents

Preparation method for 2,4,5-trichloropyrimidine compound Download PDF

Info

Publication number
CN102827085A
CN102827085A CN2012103452868A CN201210345286A CN102827085A CN 102827085 A CN102827085 A CN 102827085A CN 2012103452868 A CN2012103452868 A CN 2012103452868A CN 201210345286 A CN201210345286 A CN 201210345286A CN 102827085 A CN102827085 A CN 102827085A
Authority
CN
China
Prior art keywords
trichloropyrimidine
preparation
compound
chlorouracil
few
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012103452868A
Other languages
Chinese (zh)
Inventor
符爱清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012103452868A priority Critical patent/CN102827085A/en
Publication of CN102827085A publication Critical patent/CN102827085A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a preparation method for 2,4,5-trichloropyrimidine compound. The method comprises the following steps of adding 5-chlorouracil and thionyl chloride in dichloroethane solvent, performing heat insulation reflux reaction, after the reflux is finished, adding water in the mixture, separating the water layer, and performing distillation to distil the dichloroethane from the mixture, and thus obtaining 2,4,5-trichloropyrimidine. According to the method provided by the invention, new chlorinating agent is adopted to replace the original technology, the amount of the chlorinating agent is few, the process is easy in control, the sewage discharge is few, no phosphide pollution exists; the production cost is greatly reduced; the product quality is stable; and the product has a very favorable position in future domestic and international competition.

Description

2,4, the preparation method of 5-trichloropyrimidine compound
Technical field
The invention belongs to compound field, particularly relate to 2,4, the preparation method of 5-trichloropyrimidine compound with pyrimidine structure.
Background technology
2,4, the 5-trichloropyrimidine is the synthesis material of a kind of new reactive dyes intermediate feed and the new chemical medicine of Azelaic Acid; Continuous increase along with new reactive dyes and Azelaic Acid new drug sales volume; Its synthetic required raw material 2,4, the demand of 5-trichloropyrimidine is also in continuous growth; Therefore to its synthetic research, develop the novel environment-friendly process that is fit to industrialized production and seem particularly urgent.This product domestic corporation adopts traditional technology basically at present, and working condition is harsh, and environmental pollution is more serious.
Summary of the invention
The object of the present invention is to provide a kind of technology controlling and process easy, sewage discharge is few, 2,4 of no phosphide pollution, the preparation method of 5-trichloropyrimidine compound.
Technical solution of the present invention is:
A kind of 2,4, the preparation method of 5-trichloropyrimidine compound is characterized in that: comprise the steps:
In the solvent ethylene dichloride, drop into 5-chlorouracil and sulfur oxychloride, the insulation back flow reaction, backflow finishes, and adds entry, and branch vibration layer distills then, boils off ethylene dichloride, gets 2,4, the 5-trichloropyrimidine.
The mol ratio of 5-chlorouracil and sulfur oxychloride is 1:1-30; The insulation reflux time is 1-60 hour.
Chemosynthesis reaction equation of the present invention is following:
Figure BDA00002146052600021
The present invention adopts new chlorizating agent to replace original technology, and the chlorizating agent consumption is few, and technology controlling and process is easy; Sewage discharge is few, and no phosphide pollutes, and production cost reduces greatly; Constant product quality, this product all will be in very favorable status in the domestic and even international competition in future.
Reaction times short reaction process of the present invention is carried out under normal pressure, and is easy and simple to handle; Product yield and purity are all higher, and yield is more than 80%, and purity reaches more than 99%.
Below in conjunction with embodiment the present invention is described further.
Embodiment
A kind of 2,4, the preparation method of 5-trichloropyrimidine compound comprises the steps: in the solvent ethylene dichloride, drops into 5-chlorouracil and sulfur oxychloride; The insulation back flow reaction, backflow finishes, and adds entry, and branch vibration layer distills then; Boil off ethylene dichloride, get 2,4, the 5-trichloropyrimidine.The mol ratio of 5-chlorouracil and sulfur oxychloride is 1: 1-30 (example 1: 1,1: 15,1: 30); The insulation reflux time is 1-60 hour (routine 1h, 30h, 60h).Yield is more than 80%, and purity reaches more than 99%.

Claims (2)

1. one kind 2,4, the preparation method of 5-trichloropyrimidine compound is characterized in that: comprise the steps:
In the solvent ethylene dichloride, drop into 5-chlorouracil and sulfur oxychloride, the insulation back flow reaction, backflow finishes, and adds entry, and branch vibration layer distills then, boils off ethylene dichloride, gets 2,4, the 5-trichloropyrimidine.
2. according to claim 12,4, the preparation method of 5-trichloropyrimidine compound is characterized in that: the mol ratio of 5-chlorouracil and sulfur oxychloride is 1:1-30; The insulation reflux time is 1-60 hour.
CN2012103452868A 2012-09-17 2012-09-17 Preparation method for 2,4,5-trichloropyrimidine compound Pending CN102827085A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012103452868A CN102827085A (en) 2012-09-17 2012-09-17 Preparation method for 2,4,5-trichloropyrimidine compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012103452868A CN102827085A (en) 2012-09-17 2012-09-17 Preparation method for 2,4,5-trichloropyrimidine compound

Publications (1)

Publication Number Publication Date
CN102827085A true CN102827085A (en) 2012-12-19

Family

ID=47330424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012103452868A Pending CN102827085A (en) 2012-09-17 2012-09-17 Preparation method for 2,4,5-trichloropyrimidine compound

Country Status (1)

Country Link
CN (1) CN102827085A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113912550A (en) * 2021-11-11 2022-01-11 浙江先锋科技股份有限公司 Method for preparing 2,4, 5-trichloropyrimidine
CN115677595A (en) * 2022-10-26 2023-02-03 江苏睿实生物科技有限公司 Preparation method of 2,4, 5-trichloropyrimidine

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
WO2004016597A2 (en) * 2002-08-14 2004-02-26 Vertex Pharmaceuticals Incorporated Protein kinase inhibitors and uses thereof
US20060025433A1 (en) * 2004-07-08 2006-02-02 Boehringer Ingelheim Pharmaceuticals, Inc. Pyrimidine derivatives useful as inhibitors of PKC-theta
WO2007120339A1 (en) * 2005-12-19 2007-10-25 Genentech, Inc. Pyrimidine kinase inhibitors
CN101563327A (en) * 2006-12-19 2009-10-21 健泰科生物技术公司 Pyrimidine kinase inhibitors
WO2010118367A2 (en) * 2009-04-10 2010-10-14 Progenics Pharmaceuticals, Inc. Antiviral pyrimidines

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
WO2004016597A2 (en) * 2002-08-14 2004-02-26 Vertex Pharmaceuticals Incorporated Protein kinase inhibitors and uses thereof
US20060025433A1 (en) * 2004-07-08 2006-02-02 Boehringer Ingelheim Pharmaceuticals, Inc. Pyrimidine derivatives useful as inhibitors of PKC-theta
WO2007120339A1 (en) * 2005-12-19 2007-10-25 Genentech, Inc. Pyrimidine kinase inhibitors
CN101563327A (en) * 2006-12-19 2009-10-21 健泰科生物技术公司 Pyrimidine kinase inhibitors
WO2010118367A2 (en) * 2009-04-10 2010-10-14 Progenics Pharmaceuticals, Inc. Antiviral pyrimidines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAN WANG等: "Large-Scale Solvent-Free Chlorination of Hydroxy-Pyrimidines,-Pyridines, -Pyrazines and -Amides Using Equimolar POCl3", 《MOLECULES》 *
ZHIYUAN ZHANG等: "Design and Synthesis of Pyrimidinone and Pyrimidinedione Inhibitors of Dipeptidyl Peptidase IV", 《JOURNAL OF MEDICINAL CHEMISTRY》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113912550A (en) * 2021-11-11 2022-01-11 浙江先锋科技股份有限公司 Method for preparing 2,4, 5-trichloropyrimidine
CN115677595A (en) * 2022-10-26 2023-02-03 江苏睿实生物科技有限公司 Preparation method of 2,4, 5-trichloropyrimidine

Similar Documents

Publication Publication Date Title
CN104084230B (en) A kind of preparation method reacting solid catalyst for Knoevenagel
MX347947B (en) Method and system for preparing high-purity hydrogen chloride.
CN104151164A (en) Method for preparing methyl chloroacetate
CN102827085A (en) Preparation method for 2,4,5-trichloropyrimidine compound
CN105200089B (en) (S) -1- tertbutyloxycarbonyls -3- hydroxy piperidines preparation method and its device
CN103772185B (en) Device and method for removing moisture and heteroacids in acetic acid
CN103922940B (en) A kind of technique of producing oil of mirbane
CN102515613A (en) Method for preparing naphthalene based superplasticizer by using refined naphthalene by-product 90 naphthalene
CN104418779A (en) Preparation method of high-purity fudosteine
CN106966867A (en) A kind of three tower is thermally integrated variable-pressure rectification separation methanol, ethanol, the energy saving technique of benzene
CN106905111A (en) A kind of method of 1,6 adipic acid continuous esterification hydrogenation, 1,6 hexylene glycols of production
CN102976888A (en) Synthesizing method of p-dichlorobenzene
CN102126967B (en) Method for producing N,N-diisopropyl ethanolamine
CN105503516B (en) Between benzyl dichloride continuous production processes and device
CN101665406B (en) Method for synthesizing 4,4-bis(chloromethyl) biphenyl
CN102030650A (en) Novel process for synthesizing dimethylcyclopropanecarboxylate
CN102952020B (en) Method for preparing single or dual-alkyl substitution product of propane diamine
CN105859544A (en) High-purity oleic acid and preparation method thereof
CN106397469A (en) Continuous cycle preparation method of trimethyl borate
CN205556506U (en) Continuous production unit to dichloro benzyl
CN102330110A (en) Chlorination method for phenoxyacetic acid
CN105085381B (en) A kind of separation method of chloro-pyridine mixture
CN102351674A (en) Method for preparing 4,4-dimethyl-1-(4-chlorphenyl)-3-pentanone
CN103012170A (en) Preparation method of 4-methoxyphenethylamine
CN204874356U (en) Continuous cycle preparation technology device of trimethyl borate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121219